Jasper J. Haringman

3.2k total citations
22 papers, 1.8k citations indexed

About

Jasper J. Haringman is a scholar working on Rheumatology, Oncology and Epidemiology. According to data from OpenAlex, Jasper J. Haringman has authored 22 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Rheumatology, 4 papers in Oncology and 4 papers in Epidemiology. Recurrent topics in Jasper J. Haringman's work include Systemic Lupus Erythematosus Research (8 papers), Rheumatoid Arthritis Research and Therapies (8 papers) and Chemokine receptors and signaling (4 papers). Jasper J. Haringman is often cited by papers focused on Systemic Lupus Erythematosus Research (8 papers), Rheumatoid Arthritis Research and Therapies (8 papers) and Chemokine receptors and signaling (4 papers). Jasper J. Haringman collaborates with scholars based in Netherlands, Australia and United States. Jasper J. Haringman's co-authors include Paul P. Tak, Maarten C. Kraan, Daniëlle M. Gerlag, Tom Smeets, Aeilko H. Zwinderman, Dominique Baeten, Barry Bresnihan, Iain B. McInnes, F. C. Breedveld and Malcolm Smith and has published in prestigious journals such as Annals of the Rheumatic Diseases, The American Journal of Gastroenterology and Intensive Care Medicine.

In The Last Decade

Jasper J. Haringman

21 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jasper J. Haringman Netherlands 17 883 490 445 284 227 22 1.8k
Luis Rodríguez‐Rodríguez Spain 24 1.0k 1.1× 483 1.0× 258 0.6× 458 1.6× 205 0.9× 139 2.3k
D. Mulherin United Kingdom 20 973 1.1× 444 0.9× 153 0.3× 182 0.6× 365 1.6× 44 1.6k
C. Daïen France 27 1.1k 1.3× 572 1.2× 166 0.4× 297 1.0× 322 1.4× 77 2.2k
Tamer A. Gheita Egypt 27 1.0k 1.1× 572 1.2× 142 0.3× 342 1.2× 266 1.2× 109 2.0k
María José Santos Portugal 25 1.1k 1.2× 659 1.3× 182 0.4× 639 2.3× 397 1.7× 164 2.6k
Chris Deighton United Kingdom 23 1.5k 1.7× 514 1.0× 126 0.3× 172 0.6× 419 1.8× 73 2.4k
Patricia A. Fraser United States 27 1.7k 1.9× 976 2.0× 213 0.5× 331 1.2× 749 3.3× 58 3.1k
Ennio Giulio Favalli Italy 34 2.2k 2.5× 915 1.9× 278 0.6× 341 1.2× 864 3.8× 138 3.5k
César Pacheco‐Tena Mexico 22 1.2k 1.4× 607 1.2× 188 0.4× 349 1.2× 556 2.4× 90 1.9k
Paola de Pablo United Kingdom 24 1.6k 1.8× 380 0.8× 96 0.2× 232 0.8× 307 1.4× 52 2.6k

Countries citing papers authored by Jasper J. Haringman

Since Specialization
Citations

This map shows the geographic impact of Jasper J. Haringman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jasper J. Haringman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jasper J. Haringman more than expected).

Fields of papers citing papers by Jasper J. Haringman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jasper J. Haringman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jasper J. Haringman. The network helps show where Jasper J. Haringman may publish in the future.

Co-authorship network of co-authors of Jasper J. Haringman

This figure shows the co-authorship network connecting the top 25 collaborators of Jasper J. Haringman. A scholar is included among the top collaborators of Jasper J. Haringman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jasper J. Haringman. Jasper J. Haringman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ewoldt, Tim M. J., Matthias Gijsen, Nestor Parolya, et al.. (2023). Predicting Beta-Lactam Target Non-Attainment in ICU Patients at Treatment Initiation: Development and External Validation of Three Novel (Machine Learning) Models. Antibiotics. 12(12). 1674–1674. 4 indexed citations
2.
Horst, Peter G. J. ter, Gertjan H.J. Wagenvoort, Annemieke Dijkstra, et al.. (2022). Target attainment and pharmacokinetics of cefotaxime in critically ill patients undergoing continuous kidney replacement therapy. Journal of Antimicrobial Chemotherapy. 77(12). 3421–3426. 1 indexed citations
3.
Ewoldt, Tim M. J., Alan Abdulla, Wim J. R. Rietdijk, et al.. (2022). Model-informed precision dosing of beta-lactam antibiotics and ciprofloxacin in critically ill patients: a multicentre randomised clinical trial. Intensive Care Medicine. 48(12). 1760–1771. 60 indexed citations
4.
Hoogendoorn, Marga, Sylvia Brinkman, Rob J. Bosman, et al.. (2021). The impact of COVID-19 on nursing workload and planning of nursing staff on the Intensive Care: A prospective descriptive multicenter study. International Journal of Nursing Studies. 121. 104005–104005. 100 indexed citations
5.
Hoogendoorn, Marga, Sylvia Brinkman, Jan Jaap Spijkstra, et al.. (2020). The objective nursing workload and perceived nursing workload in Intensive Care Units: Analysis of association. International Journal of Nursing Studies. 114. 103852–103852. 19 indexed citations
6.
Hoogendoorn, Marga, et al.. (2019). Workload scoring systems in the Intensive Care and their ability to quantify the need for nursing time: A systematic literature review. International Journal of Nursing Studies. 101. 103408–103408. 49 indexed citations
7.
Hirdes, Meike M., Jan F. Monkelbaan, Jasper J. Haringman, et al.. (2012). Endoscopic Clip-Assisted Feeding Tube Placement Reduces Repeat Endoscopy Rate: Results from a Randomized Controlled Trial. The American Journal of Gastroenterology. 107(8). 1220–1227. 10 indexed citations
8.
Wijbrandts, Carla A., Clarissa E. Vergunst, Jasper J. Haringman, et al.. (2007). Absence of changes in the number of synovial sublining macrophages after ineffective treatment for rheumatoid arthritis: Implications for use of synovial sublining macrophages as a biomarker. Arthritis & Rheumatism. 56(11). 3869–3871. 94 indexed citations
9.
Haringman, Jasper J., Daniëlle M. Gerlag, Tom Smeets, et al.. (2006). A randomized controlled trial with an anti‐CCL2 (anti–monocyte chemotactic protein 1) monoclonal antibody in patients with rheumatoid arthritis. Arthritis & Rheumatism. 54(8). 2387–2392. 198 indexed citations
10.
Haringman, Jasper J., Roos L. Oostendorp, & Paul P. Tak. (2005). Targeting cellular adhesion molecules, chemokines and chemokine receptors in rheumatoid arthritis. Expert Opinion on Emerging Drugs. 10(2). 299–310. 19 indexed citations
11.
Bresnihan, Barry, Dominique Baeten, Gary S. Firestein, et al.. (2005). Synovial tissue analysis in clinical trials.. PubMed. 32(12). 2481–4. 20 indexed citations
12.
Haringman, Jasper J., Marjolein Vinkenoog, Daniëlle M. Gerlag, et al.. (2005). Reliability of computerized image analysis for the evaluation of serial synovial biopsies in randomized controlled trials in rheumatoid arthritis. Arthritis Research & Therapy. 7(4). R862–7. 67 indexed citations
13.
Gerlag, Daniëlle M., Jasper J. Haringman, Tom Smeets, et al.. (2004). Effects of oral prednisolone on biomarkers in synovial tissue and clinical improvement in rheumatoid arthritis. Arthritis & Rheumatism. 50(12). 3783–3791. 124 indexed citations
14.
Haringman, Jasper J. & Paul P. Tak. (2004). Chemokine blockade: a new era in the treatment of rheumatoid arthritis?. Arthritis Research. 6(3). 93–93. 28 indexed citations
15.
Haringman, Jasper J., Daniëlle M. Gerlag, Aeilko H. Zwinderman, et al.. (2004). Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases. 64(6). 834–838. 362 indexed citations
16.
Haringman, Jasper J., et al.. (2004). Chemokines in joint disease: the key to inflammation?. Annals of the Rheumatic Diseases. 63(10). 1186–1194. 113 indexed citations
17.
Haringman, Jasper J., et al.. (2003). Chemokine blockade and chronic inflammatory disease: proof of concept in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases. 62(8). 715–721. 164 indexed citations
18.
Kraan, Maarten C., Jasper J. Haringman, Michael Ahern, et al.. (2000). Quantification of the cell infiltrate in synovial tissue by digital image analysis. Lara D. Veeken. 39(1). 43–49. 119 indexed citations
19.
Kraan, Maarten C., Dhavalkumar D. Patel, Jasper J. Haringman, et al.. (2000). The development of clinical signs of rheumatoid synovial inflammation is associated with increased synthesis of the chemokine CXCL8 (interleukin-8). Arthritis Research & Therapy. 3(1). 65–71. 87 indexed citations
20.
Kraan, Maarten C., et al.. (1999). Immunohistological analysis of synovial tissue for differential diagnosis in early arthritis. Lara D. Veeken. 38(11). 1074–1080. 111 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026